10-K/A: Healthcare AI Acquisition Corp. Files Amended 10-K, Updates Auditor and Ownership Details

Sentiment:

Annual Results Amendment


Healthcare AI Acquisition Corp. has filed an amendment to its annual report, updating auditor information and beneficial ownership details.

Capital raiseThe company may need to raise additional capital to complete a business combination.The company may obtain working capital loans from the New Sponsor, certain of the Companys officers and directors, or through loans from third parties.Up to $1.5 million of working capital loans may be convertible into warrants.
Worse than expectedThe company identified a material weakness in its internal control over financial reporting.The company's cash balance outside of the trust account is limited.The company's ability to continue as a going concern is in doubt.

Summary

  • Healthcare AI Acquisition Corp. filed an amendment to its 2023 annual report on Form 10-K.
  • The amendment replaces the previous audit reports from BF Borgers CPA PC and Marcum LLP with a new audit report from Bush & Associates CPA, LLC.
  • The filing also updates information on the cover page and the Security Ownership of Certain Beneficial Owners Table.
  • The company had approximately $6.5 million available in its trust account as of December 31, 2023.
  • The company has until December 14, 2024 to complete a business combination.
  • The company has identified a material weakness in its internal control over financial reporting.

Sentiment

Score: 4

Explanation: The document reveals significant risks and uncertainties, including a material weakness in internal controls and a limited cash runway. While there is some positive news, such as the new auditor, the overall tone is cautious and concerning from an investment perspective.

Positives

  • The company has a new auditor, Bush & Associates CPA, LLC.
  • The company reported a net income of $4,328,377 for the year ended December 31, 2023.
  • The company has a clear deadline for completing a business combination.

Negatives

  • The company identified a material weakness in its internal control over financial reporting.
  • The company's cash balance outside of the trust account is limited.
  • The company has incurred significant costs in pursuit of its financing and acquisition plans.

Risks

  • The company may not be able to complete a business combination by December 14, 2024.
  • The company may not be able to obtain additional financing to complete a business combination.
  • The company's internal controls are not effective.
  • The company may be deemed an investment company, forcing liquidation.
  • The company faces intense competition for business combination opportunities.
  • The company's public shareholders may not have the ability to approve the initial business combination.
  • The company's public shareholders may be more incentivized to redeem their public shares than the public shareholders of other blank check companies.
  • The company may be subject to claims that reduce the funds in the trust account.
  • The company may be affected by geopolitical tensions and market volatility.
  • The company may be subject to U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS).

Future Outlook

The company is focused on completing a business combination by December 14, 2024, but there is no assurance that it will be successful.

Management Comments

  • Management anticipates that the cash held outside of the Trust Account as of December 31, 2023 might not be sufficient to allow the Company to operate until December 14, 2024.
  • Management has determined that mandatory liquidation, and subsequent dissolution, should the Company be unable to complete a business combination, raises substantial doubt about the Companys ability to continue as a going concern for the next twelve months from the issuance of these financial statements.

Industry Context

This announcement is typical for a SPAC that is nearing its deadline to complete a business combination. The change in auditors and the update to ownership details are common occurrences as SPACs progress through their lifecycle.

Comparison to Industry Standards

  • The company's cash balance in trust is relatively low compared to other SPACs at this stage, which may limit its ability to complete a larger acquisition.
  • The company's deadline of December 14, 2024, is a common timeframe for SPACs, but the lack of a definitive agreement at this stage is a concern.
  • The identification of a material weakness in internal control is not uncommon for SPACs, but it highlights the need for improved financial oversight.
  • The company's redemption rate of public shares is high, which is a common trend in the current SPAC market.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer and ChairmanNot specifiedJiande ChenDecember 28, 2023Sponsor Handover
Chief Financial Officer and DirectorNot specifiedXiaocheng PengSeptember 5, 2023Sponsor Handover
DirectorNot specifiedNat Y ChanDecember 28, 2023Sponsor Handover
DirectorNot specifiedStefan DodovDecember 28, 2023Sponsor Handover
DirectorNot specifiedManuel C. Menendez IIIDecember 28, 2023Sponsor Handover

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Audit CommitteeThe audit committee is now composed of Nat Y Chan, Stefan Dodov and Manuel C. Menendez III.December 28, 2023Ensures independent oversight of financial reporting.
Compensation CommitteeThe compensation committee is now composed of Nat Y Chan, Stefan Dodov and Manuel C. Menendez III.December 28, 2023Ensures independent oversight of executive compensation.

Related Party Transactions

  • The company has a history of related party transactions with its sponsor, including loans and administrative services agreements.
  • The company has entered into a Warrant Exchange Agreement with the Former Sponsor whereby at the time of the initial business combination, the Former Sponsor will surrender for cancelation 11,124,960 private placement warrants in exchange for the Company issuing to the Former Sponsor 500,000 Class A Shares.

Stakeholder Impact

  • Shareholders face the risk of losing their investment if a business combination is not completed by December 14, 2024.
  • Shareholders may be subject to dilution if additional shares are issued to complete a business combination.
  • Employees of a potential target company may be affected by the terms of a business combination.
  • Creditors may have claims against the trust account, potentially reducing the amount available for shareholders.

Next Steps

  • The company needs to identify and complete a business combination by December 14, 2024.
  • The company needs to address the material weakness in its internal control over financial reporting.
  • The company may need to secure additional financing to complete a business combination.

Key Dates

DateDescription
December 14, 2021Initial public offering (IPO) was consummated.
June 8, 2023Share purchase agreement for transfer of founder shares to Atticus Ale, LLC.
June 12, 2023Sponsor Handover completed, extension of business combination deadline approved.
June 29, 2023Conversion of Class B shares to Class A shares.
August 11, 2023Shareholder meeting to extend business combination deadline to December 14, 2024.
December 14, 2024Deadline to complete a business combination.

Keywords

SPAC, business combination, audit, financial reporting, internal control, warrants, redemption, trust account, merger, acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.